Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing

Published:2021-06 Issue: Volume:21 Page:592-606
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Alves Eric^ORCID,Taifour Shahama^ORCID,Dolcetti Riccardo,Chee Jonathan^ORCID,Nowak Anna K.^ORCID,Gaudieri Silvana^ORCID,Blancafort Pilar^ORCID

Funder

US Department of Defense

National Institutes of Health

Australian Research Council

Cure Brain Cancer Foundation

National Health and Medical Research Council

Cancer Council Queensland

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference183 articles.

1. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival;Curiel;Nat. Med.,2004

2. Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers;Saito;Nat. Med.,2016

3. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer;Koopman;J. Exp. Med.,2000

4. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer;Siddle;Proc. Natl. Acad. Sci. USA,2013

5. An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer;Burr;Cancer Cell,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

2. A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma;Oncology Research;2024

3. Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing;Reviews in Endocrine and Metabolic Disorders;2023-12-06

4. Bioorthogonal Reaction‐Mediated Tumor‐Selective Delivery of CRISPR/Cas9 System for Dual‐Targeted Cancer Immunotherapy;Angewandte Chemie International Edition;2023-08-03

5. Bioorthogonal Reaction‐Mediated Tumor‐Selective Delivery of CRISPR/Cas9 System for Dual‐Targeted Cancer Immunotherapy;Angewandte Chemie;2023-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3